Association between the APOE ε4 Allele and Late-Onset Alzheimer's Disease in an Ecuadorian Mestizo Population.

Q1 Neuroscience International Journal of Alzheimer's Disease Pub Date : 2017-01-01 Epub Date: 2017-12-04 DOI:10.1155/2017/1059678
Stefany Montufar, Cristian Calero, Rodrigo Vinueza, Patricio Correa, Andrea Carrera-Gonzalez, Franklin Villegas, Germania Moreta, Rosario Paredes
{"title":"Association between the APOE <i>ε</i>4 Allele and Late-Onset Alzheimer's Disease in an Ecuadorian Mestizo Population.","authors":"Stefany Montufar,&nbsp;Cristian Calero,&nbsp;Rodrigo Vinueza,&nbsp;Patricio Correa,&nbsp;Andrea Carrera-Gonzalez,&nbsp;Franklin Villegas,&nbsp;Germania Moreta,&nbsp;Rosario Paredes","doi":"10.1155/2017/1059678","DOIUrl":null,"url":null,"abstract":"<p><p>Alzheimer's disease (AD) is the most common neurodegenerative disease. It has two main pathological hallmarks: amyloid plaques and neurofibrillary tangles. The APOE <i>ε</i>4 allele has been recognized as the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD) in several populations worldwide, yet the risk varies by region and ethnicity. The aims of this study were to describe APOE allele and genotype frequencies and examine the relationship between the APOE <i>ε</i>4 allele and LOAD risk in an Ecuadorian Mestizo population. We carried out a case-control study comprising 56 individuals clinically diagnosed with probable AD (≥65 years of age) and 58 unrelated healthy control subjects (≥65 years of age). Genotyping was performed using the real-time PCR method. Our data showed that allelic and genotypic frequencies follow the trends observed in most worldwide populations. We also found a high-risk association between APOE <i>ε</i>4 allele carriers and LOAD (OR = 7.286; 95% CI = 2.824-18.799; <i>p</i> < 0.001). Therefore, we concluded that APOE <i>ε</i>4 must be considered an important genetic risk factor for LOAD in the Ecuadorian Mestizo population. Additionally, we suggest that in mixed populations the effects of admixture and ethnic identity should be differentiated when evaluating genetic contributions to Alzheimer's disease risk.</p>","PeriodicalId":13802,"journal":{"name":"International Journal of Alzheimer's Disease","volume":"2017 ","pages":"1059678"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1059678","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Alzheimer's Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2017/1059678","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/12/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 8

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease. It has two main pathological hallmarks: amyloid plaques and neurofibrillary tangles. The APOE ε4 allele has been recognized as the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD) in several populations worldwide, yet the risk varies by region and ethnicity. The aims of this study were to describe APOE allele and genotype frequencies and examine the relationship between the APOE ε4 allele and LOAD risk in an Ecuadorian Mestizo population. We carried out a case-control study comprising 56 individuals clinically diagnosed with probable AD (≥65 years of age) and 58 unrelated healthy control subjects (≥65 years of age). Genotyping was performed using the real-time PCR method. Our data showed that allelic and genotypic frequencies follow the trends observed in most worldwide populations. We also found a high-risk association between APOE ε4 allele carriers and LOAD (OR = 7.286; 95% CI = 2.824-18.799; p < 0.001). Therefore, we concluded that APOE ε4 must be considered an important genetic risk factor for LOAD in the Ecuadorian Mestizo population. Additionally, we suggest that in mixed populations the effects of admixture and ethnic identity should be differentiated when evaluating genetic contributions to Alzheimer's disease risk.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
厄瓜多尔混血人群APOE ε4等位基因与晚发性阿尔茨海默病的关系
阿尔茨海默病(AD)是最常见的神经退行性疾病。它有两个主要的病理特征:淀粉样斑块和神经原纤维缠结。APOE ε4等位基因已被认为是世界上一些人群中迟发性阿尔茨海默病(LOAD)最强的遗传风险因素,但风险因地区和种族而异。本研究的目的是描述APOE等位基因和基因型频率,并研究APOE ε4等位基因与厄瓜多尔混血人群LOAD风险之间的关系。我们进行了一项病例对照研究,包括56名临床诊断为可能AD的个体(≥65岁)和58名无关的健康对照受试者(≥65岁)。采用实时PCR法进行基因分型。我们的数据显示,等位基因和基因型频率遵循在世界上大多数人群中观察到的趋势。我们还发现APOE ε4等位基因携带者与LOAD之间存在高风险关联(OR = 7.286;95% ci = 2.824-18.799;P < 0.001)。因此,我们得出结论,APOE ε4必须被认为是厄瓜多尔混血人群中LOAD的重要遗传危险因素。此外,我们建议在评估遗传因素对阿尔茨海默病风险的影响时,应区分混合人群和种族身份的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Alzheimer's Disease
International Journal of Alzheimer's Disease Neuroscience-Behavioral Neuroscience
CiteScore
10.10
自引率
0.00%
发文量
3
审稿时长
11 weeks
期刊最新文献
Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease. Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review. Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1